The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b study of PV-10 and anti-PD-1 in advanced cutaneous melanoma.
 
Sanjiv S. Agarwala
Consulting or Advisory Role - MSD
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Merrick I. Ross
Honoraria - Amgen; Merck
Consulting or Advisory Role - Amgen; Merck
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Amgen; Merck
 
Jonathan S. Zager
Honoraria - Amgen
Consulting or Advisory Role - Amgen; Castle Biosciences; Delcath Systems; Philogen
Speakers' Bureau - Amgen
Research Funding - Amgen (Inst); Castle Biosciences (Inst); Delcath Systems (Inst); Novartis (Inst); Philogen (Inst); Provectus (Inst)
Travel, Accommodations, Expenses - Amgen
 
Keisuke Shirai
No Relationships to Disclose
 
Richard Essner
Honoraria - Castle Biosciences; Merck Serono
 
Bernard Mark Smithers
No Relationships to Disclose
 
Victoria Atkinson
No Relationships to Disclose
 
Eric Andrew Wachter
Employment - Provectus Biopharmaceuticals
Leadership - Provectus Biopharmaceuticals
Stock and Other Ownership Interests - Provectus Biopharmaceuticals
Patents, Royalties, Other Intellectual Property - Named inventor on one or more US or international patents assigned to Provectus Biopharmaceuticals